| UDI-DI | 04048675682721 |
|---|---|
| Secondary DI | |
| Nr katalogowy | 8323156 |
| Status rynkowy | Na rynku UE |
| Pierwsze wprowadzenie | Niemcy |
| Wersja EUDAMED | 2 |
| Rodzaj (EMDN) | REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › AMPHETAMINE/METHAMPHETAMINE SPECIFIC; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › BENZODIAZEPINES; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › CANNABINOIDS; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › COCAINE + COCAINE METABOLITES; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › METHADONE; REAGENTS › IMMUNOCHEMISTRY (IMMUNOLOGY) › DRUGS OF ABUSE / TOXICOLOGY › DRUGS OF ABUSE › OPIATES |
| Kody EMDN | W0102090102 AMPHETAMINE/METHAMPHETAMINE SPECIFIC W0102090104 BENZODIAZEPINES W0102090105 CANNABINOIDS W0102090106 COCAINE + COCAINE METABOLITES W0102090110 METHADONE W0102090113 OPIATES |
Dräger DrugTest 5000 STK 7
Dräger Safety AG & Co. KGaA · DE-MF-000014172
| Basic UDI-DI | B-04048675682721 |
|---|---|
| Nazwa wyrobu | Dräger DrugTest 5000 STK 7 |
| Model | |
| Klasa ryzyka | IVD, kwestie ogólne |
| Podstawa prawna | IVDD (legacy) |
| Typ | odczynnik, POCT |
| Użytek profesjonalny | tak |
Brak Danych dodatkowych – dane z backendu interfejsu EUDAMED nie zostały jeszcze pobrane.